Fair Value Measurements (Tables)

6 Months Ended

Dec. 31, 2014

Fair Value Disclosures [Abstract]

Schedule Of Fair Value Hierarchy, Assets (Liabilities) Carried At Fair Value

(in thousands)	Level 1		Level 2		Level 3			Total
Contingent consideration	$	—	$	—	$	(5,152	)	$	(5,152	)
Interest rate derivative instruments	—		580		—			580
Foreign currency exchange contracts	—		6,463		—			6,463
Total	$	—	$	7,043	$	(5,152	)	$	1,891

(in thousands)	Level 1		Level 2			Level 3			Total
Contingent consideration	$	—				$	(12,059	)	$	(12,059	)
Interest rate derivative instruments	—		1,049						1,049
Foreign currency exchange contracts	—		(15,526		)				(15,526		)
Total	$	—	$	(14,477	)	$	(12,059	)	$	(26,536	)

Fair Value Inputs, Liabilities, Quantitative Information [Table Text Block]

The recurring Level 3 fair value measurements of our contingent consideration liability include the following significant unobservable inputs:

	HERON	ClinIntel
Unobservable Input	Range	Range
Discount rate	18%	4%
Probability of achieving financial targets	100%	12.5% to 75%
Projected period of payment	August 2015	August 2016

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]

The following table provides a summary of the change in our valuation of the fair value of the contingent consideration, which was determined by Level 3 inputs:

(in thousands)	Fair Value
Balance at June 30, 2014	$	5,152
Additions of contingent consideration due to acquisitions	9,882
Change in fair value of contingent consideration	$	(2,975	)
Balance at December 31, 2014	$	12,059